Track topics on Twitter Track topics that are important to you
Thursday, June 29th 2017 at 11:00am UTC SHANGHAI–(BUSINESS WIRE)– SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that the AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration (CFDA) and meets the market …
Cet article The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System
Obtains CFDA Approval as Medical Device for in vitro Diagnostic
Use est apparu en premier sur EEI-BIOTECHFINANCES.